Bill Ackman Supports Valeant’s Allergan Offer

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan in a cash-and-stock deal valued at $45.7 billion that will give the Canadian company the Botox wrinkle treatment. Pershing Square Capital Management LP, the fund run by Bill Ackman, Allergan’s largest shareholder, supports the offer, Valeant said. Stephanie Ruhle reports on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)

Twitter's Troubles Deepen as User Growth Stalls
21:53 - Ajay Sunder, vice president of telecoms at Frost & Sullivan, discusses Twitter earnings, user growth and the challenges facing the company. He speaks to Bloomberg's Rishaad Salamat on "Trending Business." (Source: Bloomberg)
  • Seoul Closes Gaeseong Complex Over Rocket Launch
  • Is the U.S. Heading for a Recession?
  • Twitter Earnings Disappointment: What Went Wrong?